| Medical and Health Sciences | Lifetime | 626 | FR 11 | 99.97 |
| Biological Sciences | 2021-2025 | 977 | FR 19 | 98.93 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 40 | FR 1 | 99.88 |
| Medical Genetics | Lifetime | 34 | FR 1 | 99.76 |
| Cognitive Neuroscience | Lifetime | 157 | FR 4 | 99.70 |
| Epidemiology | Lifetime | 610 | FR 21 | 99.24 |
| Neuroscience of Neurology | Lifetime | 145 | FR 2 | 98.85 |
| Clinical Neurology | Lifetime | 419 | FR 12 | 98.28 |
| Developmental Neuroscience | Lifetime | 394 | FR 12 | 83.90 |
| Cognitive Neuroscience | 2021-2025 | 74 | FR 6 | 98.93 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 96 | FR 2 | 98.40 |
| Medical Genetics | 2021-2025 | 64 | FR 2 | 98.28 |
| Developmental Neuroscience | 2021-2025 | 13 | FR 1 | 93.83 |
| Epidemiology | 2021-2025 | 905 | FR 29 | 90.90 |
| Neuroscience of Neurology | 2021-2025 | 328 | FR 7 | 74.37 |
| Meningioma and schwannoma management | Lifetime | 9 | FR 1 | 99.92 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 18 | FR 1 | 99.85 |
| Glioma Diagnosis and Treatment | Lifetime | 35 | FR 1 | 99.87 |
| Neurobiology of Language and Bilingualism | Lifetime | 17 | FR 1 | 99.66 |
| Functional Brain Connectivity Studies | Lifetime | 107 | FR 1 | 99.70 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 38 | FR 1 | 99.50 |
| Brain Metastases and Treatment | Lifetime | 58 | FR 1 | 99.43 |
| Intraoperative Neuromonitoring and Anesthetic Effects | Lifetime | 11 | FR 1 | 99.09 |
| Advanced MRI Techniques and Applications | Lifetime | 217 | FR 4 | 99.35 |
| EEG and Brain-Computer Interfaces | Lifetime | 455 | FR 14 | 98.47 |
| Epilepsy research and treatment | Lifetime | 344 | FR 19 | 98.34 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 692 | FR 12 | 98.11 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 249 | FR 18 | 98.18 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 191 | FR 10 | 97.81 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 433 | FR 15 | 97.74 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 676 | FR 50 | 97.38 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 495 | FR 12 | 96.54 |
| Ophthalmology and Eye Disorders | Lifetime | 510 | FR 10 | 96.01 |
| Cancer-related cognitive impairment studies | Lifetime | 291 | FR 3 | 93.84 |
| Peripheral Nerve Disorders | Lifetime | 616 | FR 25 | 93.69 |
| Spinal Dysraphism and Malformations | Lifetime | 513 | FR 10 | 93.21 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 916 | FR 45 | 93.25 |
| Motor Control and Adaptation | Lifetime | 941 | FR 54 | 92.85 |
| Action Observation and Synchronization | Lifetime | 768 | FR 39 | 91.45 |
| Spatial Neglect and Hemispheric Dysfunction | Lifetime | 357 | FR 24 | 91.59 |
| Hemispheric Asymmetry in Neuroscience | Lifetime | 364 | FR 23 | 90.67 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 39 | FR 2 | 98.44 |
| Meningioma and schwannoma management | 2021-2025 | 28 | FR 2 | 98.73 |
| Glioma Diagnosis and Treatment | 2021-2025 | 92 | FR 3 | 98.88 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 18 | FR 1 | 97.65 |
| Functional Brain Connectivity Studies | 2021-2025 | 134 | FR 3 | 98.40 |
| Neurobiology of Language and Bilingualism | 2021-2025 | 26 | FR 3 | 97.34 |
| Brain Metastases and Treatment | 2021-2025 | 182 | FR 6 | 94.27 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 381 | FR 5 | 83.38 |
| Cancer-related cognitive impairment studies | 2021-2025 | 310 | FR 7 | 82.40 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 723 | FR 17 | 84.17 |
| Ophthalmology and Eye Disorders | 2021-2025 | 430 | FR 5 | 80.67 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 827 | FR 20 | 80.06 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 597 | FR 38 | 76.80 |
| Music Therapy and Health | 2021-2025 | 540 | FR 4 | 63.44 |
